JPWO2022107737A1 - - Google Patents

Info

Publication number
JPWO2022107737A1
JPWO2022107737A1 JP2022563754A JP2022563754A JPWO2022107737A1 JP WO2022107737 A1 JPWO2022107737 A1 JP WO2022107737A1 JP 2022563754 A JP2022563754 A JP 2022563754A JP 2022563754 A JP2022563754 A JP 2022563754A JP WO2022107737 A1 JPWO2022107737 A1 JP WO2022107737A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022563754A
Other versions
JPWO2022107737A5 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022107737A1 publication Critical patent/JPWO2022107737A1/ja
Publication of JPWO2022107737A5 publication Critical patent/JPWO2022107737A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1002—Coronaviridae
    • C07K16/1003—Severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2 or Covid-19]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
JP2022563754A 2020-11-17 2021-11-16 Pending JPWO2022107737A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020190706 2020-11-17
PCT/JP2021/041983 WO2022107737A1 (ja) 2020-11-17 2021-11-16 ＳＡＲＳ－ＣｏＶ－２の検出キットおよびＳＡＲＳ－ＣｏＶ－２の検出方法

Publications (2)

Publication Number Publication Date
JPWO2022107737A1 true JPWO2022107737A1 (ja) 2022-05-27
JPWO2022107737A5 JPWO2022107737A5 (ja) 2023-11-16

Family

ID=81708068

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022563754A Pending JPWO2022107737A1 (ja) 2020-11-17 2021-11-16

Country Status (5)

Country Link
US (1) US20230341398A1 (ja)
EP (1) EP4249508A1 (ja)
JP (1) JPWO2022107737A1 (ja)
CN (1) CN116635411A (ja)
WO (1) WO2022107737A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4365195A1 (en) * 2021-06-30 2024-05-08 Tauns Laboratories, Inc. Antibody against nucleocapsid protein of sars-cov-2
JP7226878B1 (ja) 2022-06-30 2023-02-21 積水メディカル株式会社 検査方法、イムノクロマトグラフィーテストストリップ、及びイムノクロマトグラフィーキット
WO2024070698A1 (ja) * 2022-09-26 2024-04-04 富士フイルム株式会社 イムノクロマトグラフカートリッジ

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02130473A (ja) * 1988-11-11 1990-05-18 Sanyo Chem Ind Ltd 杭原性物質の免疫測定法および免疫測定試薬
US6020117A (en) 1998-09-30 2000-02-01 Eastman Kodak Company Thermally processable imaging element
US8043866B2 (en) 2007-09-28 2011-10-25 Fujifilm Corporation Immunochromatography method
JP5430995B2 (ja) 2009-03-30 2014-03-05 富士フイルム株式会社 アッセイ方法およびアッセイ用デバイス
JP5276568B2 (ja) 2009-11-05 2013-08-28 富士フイルム株式会社 アッセイ用デバイス
JP6570652B2 (ja) 2015-12-18 2019-09-04 富士フイルム株式会社 イムノクロマトグラフキット
JP7141458B2 (ja) * 2018-08-29 2022-09-22 富士フイルム株式会社 クロマトグラフキットおよびクロマトグラフ方法
CN111398589A (zh) * 2020-02-13 2020-07-10 北京华科泰生物技术股份有限公司 一种快速检测新型冠状病毒n蛋白的免疫层析试剂盒及其制备方法和应用
CN111269313B (zh) * 2020-03-07 2021-05-28 北京舜景生物医药技术有限公司 一种用于检测新型冠状病毒的单克隆抗体及其制备试剂盒的用途
CN111471103A (zh) 2020-03-20 2020-07-31 唐山怡安生物工程有限公司 一种新冠病毒（2019-nCOV）的异源抗体及其制备方法
CN111560070B (zh) 2020-05-27 2021-10-01 江苏省疾病预防控制中心(江苏省公共卫生研究院) 针对新型冠状病毒np蛋白的抗体及其检测应用

Also Published As

Publication number Publication date
EP4249508A1 (en) 2023-09-27
CN116635411A (zh) 2023-08-22
US20230341398A1 (en) 2023-10-26
WO2022107737A1 (ja) 2022-05-27

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ja)
BR112023012656A2 (ja)
BR112021014123A2 (ja)
BR112022024743A2 (ja)
BR102021018859A2 (ja)
BR102021015500A2 (ja)
BR112022009896A2 (ja)
BR102021007058A2 (ja)
BR102020022030A2 (ja)
BR112023011738A2 (ja)
BR112023016292A2 (ja)
BR112023004146A2 (ja)
BR112023011610A2 (ja)
BR112023011539A2 (ja)
BR112023008976A2 (ja)
BR112023009656A2 (ja)
BR112023006729A2 (ja)
BR102021020147A2 (ja)
BR102021018926A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016375A2 (ja)
BR102021016176A2 (ja)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230426

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230426

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231102

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240507